Skip to main content
BEAT
NASDAQ Life Sciences

HeartBeam Completes ALIGN-ACS Enrollment, Eyes FDA Pivotal Study

Tom Rudovsky · Reported by Wiseek News
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.37
Mkt Cap
$20.274M
52W Low
$0.355
52W High
$4
52W Position info
4.2% above low
Off High info
91% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

BEAT is trading near its 52-week low of $0.355 (4.2% above the low).

Summary

HeartBeam has completed enrollment in its ALIGN-ACS study ahead of schedule and will present results at TCT 2026. The company also advanced HEADSTART-ACS enrollment and submitted a pre-submission to the FDA for a pivotal MI study. Its 12-lead patch is progressing toward FDA clearance, with commercialization planned through a strategic partner. These updates follow a period of financial strain, including a going concern warning and a Nasdaq bid price deficiency. The rapid enrollment and regulatory progress could improve the company's outlook, but the stock remains near its 52-week low at $0.37.

At the time of this announcement, BEAT was trading at $0.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.3M. The 52-week trading range was $0.36 to $4.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Nov 12, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3969
Real-time Price: $0.310 info
Change: -$0.0869 (-22%) info
Market Cap: $19.557M info
BEAT
Nov 12, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.4053
Real-time Price: $0.310 info
Change: -$0.0953 (-24%) info
Market Cap: $19.557M info
BEAT
Nov 02, 2026, 8:31 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.5402
Real-time Price: $0.310 info
Change: -$0.2302 (-43%) info
Market Cap: $19.557M info
BEAT
Oct 26, 2026, 8:38 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.4061
Real-time Price: $0.310 info
Change: -$0.0961 (-24%) info
Market Cap: $19.557M info
BEAT
Oct 05, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $0.697014
Real-time Price: $0.310 info
Change: -$0.387014 (-56%) info
Market Cap: $19.557M info